These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 3727485)

  • 1. [Steroid hormone receptors and survival in breast cancer patients].
    Ivanova OA; Tsyrlina EV; Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1986; 32(6):71-6. PubMed ID: 3727485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cancer of the breast and the receptor status].
    Buonomo O; Serao A; Muggianu A; Guglielmelli E; Davoli E; Amori A
    G Chir; 1991 Apr; 12(4):274-7. PubMed ID: 1911078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone and estrogen receptors as prognostic variables in breast cancer.
    Mason BH; Holdaway IM; Mullins PR; Yee LH; Kay RG
    Cancer Res; 1983 Jun; 43(6):2985-90. PubMed ID: 6850609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estradiol and progesterone receptors in loco-regional breast cancer. Clinical and prognostic correlations].
    Bolla M; Chedin M; Chambaz E; Gabelle P
    Sem Hop; 1984 Jan; 60(2):91-6. PubMed ID: 6322331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
    Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
    Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Demonstration of the effect of estrogen and progesterone receptors on survival in breast cancer without cytostatic and hormonal treatment in a small set of patients].
    Hochmann J
    Klin Onkol; 2010; 23(1):25-33. PubMed ID: 20192071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
    Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
    Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor-negative, progesterone receptor-positive breast carcinoma: poor clinical outcome.
    Keshgegian AA; Cnaan A
    Arch Pathol Lab Med; 1996 Oct; 120(10):970-3. PubMed ID: 12046611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone receptors and breast cancer prognosis].
    Saez S; Pichon MF
    Pathol Biol (Paris); 1983 Dec; 31(10):801-8. PubMed ID: 6366701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of results of estrogen and progesterone receptor assays performed in a community hospital.
    Szakacs JG; Arroyo JG; Girgenti AJ
    Ann Clin Lab Sci; 1986; 16(4):266-73. PubMed ID: 3740795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of steroid receptors in synchronous tissues with survival in breast cancer patients.
    Bhatavdekar JM; Patel DD; Karelia NH; Suthar TP; Shah NG; Vora HH; Ghosh N; Nadkarni SP; Balar DB
    Neoplasma; 1993; 40(3):177-80. PubMed ID: 8350965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anatomopathology of breast cancer and hormone receptors].
    Contesso G; Delarue JC; Mouriesse H; May-Levin F; Garnier H
    Pathol Biol (Paris); 1983 Nov; 31(9):747-54. PubMed ID: 6361672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oestrogen-progesterone receptor ratio: an indicator of breast cancer evolution.
    Cherubini M; Baxa P; Guarino G
    Chir Ital; 2002; 54(4):423-8. PubMed ID: 12239750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
    Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
    Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval].
    Zielinski CC; Kuzmits R; Kubista E; Salzer H; Staffen A; Aiginger P; Spona J
    Wien Klin Wochenschr; 1985 May; 97(11):493-7. PubMed ID: 4013343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of estradiol and progesterone receptors in stage I and II breast cancer with an adjuvant treatment].
    Bolla M; Bonnabel P; Chedin M; Villemain D; Zins M; Mousseau M; Chambaz E
    Bull Cancer; 1987; 74(6):623-30. PubMed ID: 3435786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients].
    Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L
    J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear areas in breast cancer: relationship with estrogen and progesterone receptor expression.
    Maiorana A; Cavallari V; Bagni A; Ussia F; Maiorana MC; Fano RA
    Anal Cell Pathol; 1996 Aug; 11(3):199-209. PubMed ID: 8888955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.